Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a non-standard, multi-ingredient combination consisting of Astragalus membranaceus (a traditional herbal medicine), budesonide (a synthetic inhaled corticosteroid), and terbutaline (a short-acting beta-2 adrenergic agonist bronchodilator). - **Astragalus membranaceus** is an adaptogenic herb used in traditional Chinese medicine for its purported immunomodulatory, anti-inflammatory, antioxidant, and anti-aging effects. It is commonly promoted as a dietary supplement for immune support and respiratory health but lacks robust clinical evidence for most indications[1][3][5]. - **Budesonide** is an inhaled corticosteroid that reduces airway inflammation by binding to the glucocorticoid receptor, suppressing pro-inflammatory gene expression. It is widely used in asthma and chronic obstructive pulmonary disease (COPD) management[6][8]. - **Terbutaline** is a selective beta-2 adrenergic receptor agonist that acts as a bronchodilator by relaxing bronchial smooth muscle. It provides rapid relief from bronchospasm in conditions like asthma[6][8]. There are no known approved pharmaceutical products or fixed-dose combinations containing all three ingredients together; this combination would be considered experimental or investigational if used clinically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on astragalus membranaceus + budesonide + terbutaline.